Chronic use of renin–angiotensin–aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis

Hypertension is a prevalent condition among SARS-CoV-2 infected patients. Whether renin–angiotensin–aldosterone system (RAAS) inhibitors are beneficial or harmful is controversial. We have performed a national retrospective, nonexperimental comparative study from two tertiary hospitals to evaluate t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Medicina clinica 2022-04, Vol.158 (7), p.315-323
Hauptverfasser:	Aparisi, Álvaro, Catalá, Pablo, Amat-Santos, Ignacio J., Marcos-Mangas, Marta, López-Otero, Diego, Veras, Carlos, López-Pais, Javier, Cabezón-Villalba, Gonzalo, Cacho Antonio, Carla Eugenia, Candela, Jordi, Antúnez-Muiños, Pablo, Gil, José Francisco, González Ferrero, Teba, Rojas, Gino, Pérez-Poza, Marta, Uribarri, Aitor, Otero-García, Oscar, García-Granja, Pablo Elpidio, Jiménez Ramos, Víctor, Revilla, Ana, Dueñas, Carlos, Gómez, Itzíar, González-Juanatey, José Ramón, San Román, J. Alberto
Format:	Artikel
Sprache:	eng
Schlagworte:	Aldosterone - pharmacology Aldosterone - therapeutic use Angiotensin II receptor blockers Angiotensin Receptor Antagonists - pharmacology Angiotensin Receptor Antagonists - therapeutic use Angiotensin-converting-enzyme inhibitors Angiotensins - pharmacology Angiotensins - therapeutic use Antagonistas de los receptores de la angiotensina II Antihypertensive Agents - therapeutic use COVID-19 Hipertensión arterial Humans Hypertension Hypertension - complications Hypertension - drug therapy Inhibidores de la enzima convertidora de angiotensina Meta-analysis Metaanális Mineralocorticoid Receptor Antagonists - therapeutic use Original Registries Renin - pharmacology Renin - therapeutic use Renin-Angiotensin System Retrospective Studies SARS-CoV-2
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!